Defining neurodegenerative diseases

British Medical Journal

Volumn 324, Issue 7352, 2002, Pages 1465-1466

  Williams, Adrian ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; PARKIN; PRION PROTEIN; PROTEIN; SERINE PROTEINASE INHIBITOR; SUPEROXIDE DISMUTASE;

AGE; AGING; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIAGNOSTIC APPROACH ROUTE; EDITORIAL; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HUMAN; NERVE DEGENERATION; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM; SYNDROME DELINEATION;

EID: 0037157533     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.324.7352.1465     Document Type: Editorial

References (11)

1. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
2. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
3. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
4. Amytrophic lateral sclerosis. Unfolding the toxicity of the misfolded
5. The cerebal proteinopathies
6. Familial encephalopathy with neuroserpin inclusion bodies
7. Chronic parkinsonism in humans due to a product of meperdine-analog synthesis
8. Expression of nicotinamide N-methyltransferase (E.C.2.1.1.1) in the parkinsonian brain
9. Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrants to Guam
10. Reversing neurodegeneration: A promise unfolds
11. Rewiring the parkinsonian brain